Clinical trial · Observational
Prostate Cancer Utilities and Cost-Effectiveness Analysis
NCT00203918CI-TRIAL-00029349completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to help doctors and patients make better decisions about prostate cancer treatment. This research is being done because we do not know how patient preferences for health states related to prostate cancer affect the final treatment decision.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| patient utility scores (i.e. patient preference weights) | Behavioral | — | UNRESOLVED |
| Survey, interview | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Prostate biopsies
- description
- Males undergoing prostate biopsies
- interventionNames
- Behavioral: Survey, interview
- Behavioral: patient utility scores (i.e. patient preference weights)
Primary outcomes (1)
- measure
- Utility scores for treatment outcomes
- timeFrame
- 90 days after enrollment
- description
- Patient utility scores (i.e. patient preference weights) are calculated using survery data will determine which prostate cancer treatment would be most cost-effective for each subject. Patients will be contacted by phone and patient records will be reviewed 90 days after the survey has been completed to determine whether this data reflects actual treatment decisions.
Secondary outcomes (1)
- measure
- Anxiety levels
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients undergoing prostate biopsy Exclusion Criteria: * Women and children will be excluded, as prostate cancer occurs in men only * Diagnosis of dementia
References
Publications (0)
Data not yet available
No reference posted for this study.